Related Experiment Videos
Nephrotoxicity associated with combined gentamicin-amphotericin B therapy
Nephron
|January 1, 1977
Abstract:
The administration of a low total dose of amphotericin B to four consecutive patients already receiving gentamicin resulted in a deterioration of renal function in all. No other cause of the renal dysfunction was apparent in three cases. It appears probable that these drugs exhibit synergistic nephrotoxicity.
Insights
Concurrent administration of amphotericin B and gentamicin may cause synergistic nephrotoxicity, leading to kidney function decline. This drug interaction requires careful monitoring in patients receiving both medications.
Area of Science:
- Nephrology
- Pharmacology
- Clinical Medicine
Background:
- Gentamicin, an aminoglycoside antibiotic, is known for its potential nephrotoxicity.
- Amphotericin B, an antifungal agent, also carries a risk of renal adverse effects.
Observation:
- Four patients receiving gentamicin concurrently with a low total dose of amphotericin B experienced significant renal function deterioration.
- In three of these cases, no alternative cause for the observed renal dysfunction was identified.
Findings:
- The combined use of amphotericin B and gentamicin appears to result in synergistic nephrotoxicity.
- This synergistic effect suggests an enhanced risk of kidney damage when these two drugs are co-administered.
Implications:
- Clinicians should exercise caution when prescribing amphotericin B to patients already on gentamicin therapy.
- Close monitoring of renal function is crucial in patients receiving this drug combination to mitigate potential kidney injury.